Global Fill Finish Manufacturing Market Insights Forecasts to 2030

• The Fill Finish Manufacturing Market Size was valued at USD 8.7 Billion in 2021.
• The market is growing at a CAGR of 11.7% from 2022 to 2030
• The global Fill Finish Manufacturing Market is expected to reach USD 22.1 billion by 2030
• Asia Pacific is expected to grow the fastest during the forecast period

The global Fill Finish Manufacturing Market is expected to reach USD 22.1 billion by 2030, at a CAGR of 11.7% during the forecast period 2022 to 2030.

Fill and finish is a process to fill vials with vaccine and finishing the packaging process of medicines needed for distribution. Different manufacturers of vaccines use third parties for fill and finish their vaccines. Fill finish processing comes after formation of active agent through cell culture or fermentation, bioprocessing, and downstream purification. After going through all the processes, the final product will come with the higher value.

Impact of COVID 19 on Global Fill Finish Manufacturing Market

Biotechnological and pharmaceutical companies are collaborating with governments of various nations to overcome the COVID 19 pandemic. This is done by introducing vaccines for scheduling medicines supply chain challenges. Moreover, there are about 115 vaccine candidates and 155 molecules which are under research and development. Furthermore, hydroxychloroquine, which is one of the most commonly used drugs have witnessed a surge in the demand for COVID 19 management. The increase in the demand of drugs have introduced numerous opportunities for key market players who are involved in COVID 19 drugs management. Thus, due to the rise in the demand for COVID 19 treatment medicines and vaccines have resulted huge profits to the biotechnology and pharmaceutical industry.

Key Market Drivers

Rise in the number of biopharmaceutical companies to drive the market

The increase in the number of biopharmaceutical companies as well as the increasing demand for biologics in developed as well as developing economies is anticipated to propel the market growth. Furthermore, novel procedures and equipment play the most crucial role in making different biopharmaceutical products which also maintains product value that in turn boost the market growth.

Increasing penetration of CMO in biotech industry to boost the growth

The increasing penetration of contract manufacturing organizations (CMO) in different biotech companies is contributing towards the growth of the global fill finish manufacturing market. Apart from this, various small size biopharmaceutical and biotechnological companies are involved in outsourcing their fill finish operation to CMO because the entire production cost is incurred by the company and CMO due to which the chances of risk faced is reduced.

Key Challenging Factors

High costs involved with RABs and isolators to restrain the market growth

Isolators and RABs come with advanced functionalities and features. These equipment offers an enclosed environment that lessens the risk of contamination. Not only this but also isolators and RABs are costly than standalone systems which limits their adoption by small scale companies. In fact, in developing and underdeveloped countries, the use of isolators and RABs are lesser as compared to standalone systems which in turn hampers the market growth.

Market Segmentation

Product Insights

Consumables segment holds the largest market share over the forecast period.

Based on the product, the global fill finish manufacturing market is segmented into consumables and instruments. Among these, the consumables segment is dominating the market with the largest market share over the forecast period. The main reason behind the growth of the segment is its longer shelf life and increasing use of disposable packaging for biologics. Furthermore, the prefilled syringes are likely to increase the market revenue owing to the increasing adoption in different applications like lyophilization and rising fill finish outsourcing.

End Use Insights

Contract Manufacturing Organization is dominating the market with the largest market share over the forecast period

On the basis of end use, the global fill finish manufacturing market is segmented into pharmaceutical and biopharmaceutical companies, contract manufacturing organizations, research and development laboratories, and academic research institutions. Among these, the contract manufacturing organization is dominating the market with the largest market share over the forecast period. The growth is attributed to the increasing production of new medicines and outsourcing manufacturing of drug substances. Furthermore, it provides drug development services and handles drug innovation manufacturing of pharmaceutical products which are driving the segmental growth.

Regional Insights

Europe is dominating the market with the largest market share over the forecast period.

Europe is dominating the market with the largest market share and is going to continue its dominance over the forecast period due to the increasing concerns of chronic ailments among the elderly people as well as the launch of new medications. Apart from this, the increasing investments in research and developments in developing cost friendly biologics is nations like Germany, Italy, and France is going to propel the market growth over the forecast period.

Asia Pacific, on the other hand, is anticipated to witness the fastest market growth over the forecast period due to the increasing investment done by the government for improving healthcare infrastructure as well as clinical research centers. Furthermore, the increasing penetration of contract manufacturing organizations with various leading pharmaceutical companies and development of fill finish manufacturing plants in India, Japan, and China is going to propel the market.

Recent Market Developments

• In March 2022, SGD Pharma has launched its sterile 100 ml molded glass vials which will help in protecting drug stability and reduced scratches on vials for enhancing visual inspection.
• In February 2022, Moderna and Thermo Fisher scientific have collaborated with each other to manufacture COVID 19 vaccines and various mRNA medicines in the US.

List of Key Companies

• Becton, Dickson and Company
• Syntegon Technology GmbH
• I.M.A. (IndustriaMacchineAutomatiche) S.p.A.
• Stevanato Group
• West Pharmaceutical Services, Inc.
• OPTIMA Packaging Group GmbH
• Bausch+Strobel
• Groninger& Co. GmbH
• Gerresheimer AG
• Maquinaria Industrial Dara
• Robert Bosch

Market Segment

This study forecasts revenue at global, regional, and country levels from 2019 to 2030. Spherical Insights has segmented the global Fill Finish Manufacturing Market based on the below-mentioned segments:

Fill Finish Manufacturing Market, Product Analysis

• Consumables
• Instruments

Fill Finish Manufacturing Market, End Use Analysis

• Pharmaceutical and biopharmaceutical companies
• Contract manufacturing organizations
• Research and development laboratories
• Academic research institutions

Fill Finish Manufacturing Market, Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • Uk
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of Middle East & Africa